CORRECTION article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1659836
Correction: Myeloid Zinc Finger 1: insights into its oncogenic potential, prognostic value, and impact on immune microenvironment across cancers
Provisionally accepted
- 1Department of Thyroid and Breast Oncological Surgery, Huai’an Second People’s Hospital, The Affiliated Huaian Hospital of Xuzhou Medical University, Huai’an, Jiangsu, China, Huai’an, Jiangsu, China
- 2Shanghai Jiao Tong University, Shanghai, China
- 3Institute of Developmental and Regenerative Medicine, Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
- 4Department of Oncology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai'an, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Notice of Correction:Regarding Affiliation Information of Authors in our recently published article: "Myeloid Zinc Finger 1: insights into its oncogenic potential, prognostic value, and impact on immune microenvironment across cancers."
Keywords: Myeloid zinc finger 1, Pan-cancer, tumor immunity, prognostic biomarker, immunotherapy drug susceptibility
Received: 04 Jul 2025; Accepted: 07 Jul 2025.
Copyright: © 2025 Sun, Zhang and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Aijun Sun, Department of Thyroid and Breast Oncological Surgery, Huai’an Second People’s Hospital, The Affiliated Huaian Hospital of Xuzhou Medical University, Huai’an, Jiangsu, China, Huai’an, Jiangsu, China
Shasha Zhang, Shanghai Jiao Tong University, Shanghai, China
Chao Jiang, Department of Oncology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai'an, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.